25 results
Thumbnail

D1.92 - Optimizing Aspirin Oral Provocation Testing in Suspected NSAID Hypersensitivity: A Real-World Protocol Analysis

Thumbnail

D1.90 - Soft Tissue Loss Due to Allergic Reaction to Ahesive System during Orthodontic Treatment: A Case Report

Thumbnail

D1.91 - Characterization of Bet v1 Sensitized Patients in Madrid: A Real Life Study

Thumbnail

D1.93 - Isolated Generalized Pruritus Associated with SGLT2 Inhibitors: A Case Series with Negative Allergy Work-up

Thumbnail

D1.94 - Vancomycin- and Meropenem-Induced DRESS Confirmed by the Lymphocyte Transformation Test: A Synergistic Effect in Severe Drug Reactions

Thumbnail

D1.95 - Utility and safety of Patch Testing in anti-epileptic Induced DRESS: Diagnostic sensitivity and cross-reactivity profiling

Thumbnail

D1.96 - Assessment of sensitivity to Lipid Transfer Proteins in allergic patients in the Republic of Moldova

Thumbnail

D1.98 - Comparative Evaluation of Basal Serum Tryptase Determinants: Differential Impact of KIT D816V Allelic Load and HaT Gene Copy Number

Thumbnail

D1.99 - Allergic contact dermatitis caused by Trofoblastin

Thumbnail

D1.100 - Deciphering Multiple Drug Allergy syndrome: True Allergy or Pro-inflammatory Response ?

Thumbnail

D1.101 - Colchicine-induced hepatitis: a case of drug interaction involving rivaroxaban

Thumbnail

D1.102 - Furosemide-induced erythroderma: a diagnosis to consider

Thumbnail

D1.103 - Successful Class Switching of SGLT2 Inhibitors Following Empagliflozin-Induced Maculopapular Exanthema: A Case Report

Thumbnail

D1.97 - To FeNO or Not to FeNO: Is It a Practical Tool in Daily Management of Chronic Cough?

Thumbnail

D2.490 - Consistent efficacy of a seasonal 300IR birch pollen sublingual immunotherapy in children and adolescents during worst pollen exposure: results of the YOBI trial

Thumbnail

D2.491 - Efficacy of a 300IR birch liquid sublingual immunotherapy during the alder and hazel pollen seasons: results of the YOBI trial

Thumbnail

D2.492 - Efficacy and safety of a 300IR daily dose of a SLIT of birch pollen allergen extract in children and adolescents with allergic rhinoconjunctivitis: results from the YOBI trial

Thumbnail

D2.494 - Tralokinumab treatment in adults with atopic dermatitis who were previously treated with dupilumab: 12-months real-world data from the TRACE study

Thumbnail

D2.495 - Treatment with Izicopan (INF904), an oral anti-C5aR inhibitor improves efficacy and safety in patients with chronic spontaneous urticaria: results from a Phase 2a study

Thumbnail

D2.496 - First-in-Human Phase I Clinical Outcomes of BxC-I17e Enriched with HSP70/miR-22-3p in Atopic Dermatitis